Centene (CNC) Receives a Hold from Mizuho Securities

Mizuho Securities analyst Ann Hynes maintained a Hold rating on Centene (CNCResearch Report) on June 17 and set a price target of $84.00. The company’s shares closed last Tuesday at $80.86.

According to, Hynes is a 4-star analyst with an average return of 6.1% and a 51.6% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, Molina Healthcare, and Acadia Healthcare.

Currently, the analyst consensus on Centene is a Moderate Buy with an average price target of $94.70.

See Insiders’ Hot Stocks on TipRanks >>

Centene’s market cap is currently $44.64B and has a P/E ratio of 30.28.

Based on the recent corporate insider activity of 124 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CNC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene Corporation is a diversified healthcare company that primarily engages in providing programs and services to the government sponsored healthcare programs. The company is also engaged in providing education and outreach programs to assist members in accessing quality and appropriate healthcare services.

Read More on CNC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More